Arcutis Biotherapeutics director Terrie Curran disposes of 1,072 common shares worth $27,927.31

Reuters2026/08/24 20:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Arcutis Biotherapeutics director Terrie Curran exercised stock options for 1,072 common shares at USD 7.51 on Aug. 20, 2026.
Curran sold 1,072 common shares at a weighted average price of USD 26.04 on the same day.
Directly held common shares fell to 23,526 following the transactions.
Directly held stock options decreased to 11,148.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-058648), on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Arcutis Biotherapeutics director Terrie Curran disposes of 1,072 common shares worth $27,927.31

You may also like

Crypto prices